P320: High Cytomegalovirus DNA load in mucosal biopsies predicts steroid failure as well as colectomy in acute severe ulcerative colitis
ECCO '19 Copenhagen
2019
P321: On effectiveness, safety, and TDM of thioguanine in a cohort of 274 patients with IBD, intolerant for conventional thiopurines
ECCO '19 Copenhagen
2019
P322: Disease-related worries and concerns in patients with ulcerative colitis: 1-year data from ICONIC
ECCO '19 Copenhagen
2019
P324: Tuberculosis infection under anti-TNF therapy – should we be looking for it?
ECCO '19 Copenhagen
2019
P325: Integrating efficacy and safety of vedolizumab and other advanced therapies for the treatment of ulcerative colitis: Results from a network meta-analysis
ECCO '19 Copenhagen
2019
P326: Audit and review of infliximab therapeutic drug monitoring and prescribing practices in paediatric inflammatory bowel disease (IBD) patients
ECCO '19 Copenhagen
2019
P327: Segmental colectomy for ulcerative colitis: a new paradigm? A multi-centric study in 72 patients
ECCO '19 Copenhagen
2019
P328: Low vitamin K, vitamin D and calcium dietary intake in IBD patients represents a potentially reversible risk factor for osteoporosis
ECCO '19 Copenhagen
2019
P329: Adalimumab therapeutic drug monitoring test validated for measuring ABP 501 biosimilar
ECCO '19 Copenhagen
2019
P330: A national survey on therapeutic education in inflammatory bowel disease by an association of caregivers and expert patients: French Association for Therapeutic Education in inflammatory bowel disease (AFEMI)
ECCO '19 Copenhagen
2019
P331: Real-world assessment of biological treatment of inflammatory bowel disease at an Austrian Referral Centre: the ULTIMATE study
ECCO '19 Copenhagen
2019
P332: Multinational comparisons of practices in overseas travel in Crohn’s disease and ulcerative colitis
ECCO '19 Copenhagen
2019
P333: Associations between multiple immunosuppressive treatments before surgery and surgical morbidity in patients with ulcerative colitis during the era of biologics
ECCO '19 Copenhagen
2019
P334: Chromoendoscopy is superior to white light endoscopy for the detection of advanced colonic neoplasia in patients with inflammatory bowel disease
ECCO '19 Copenhagen
2019
P335: Long-term follow-up of switching from original infliximab to infliximab biosimilar: real-world data
ECCO '19 Copenhagen
2019
P336: Behavioural treatment options for psychological comorbidities in patients with inflammatory bowel disease: a systematic literature review
ECCO '19 Copenhagen
2019
P337: Switching from originator infliximab to CT-P13: single-centre experience from the UK
ECCO '19 Copenhagen
2019